Biocryst Pharmaceuticals (BCRX) Q3 2023 Earnings

2NovConfirmed
Q4 2022
Q1 2023
Q2 2023
Q3 2023
-0.38
-0.31
-0.24
-0.17

Details

Expected EPS
-0.23
Actual EPS
-0.19
Surprise EPS
0.04
Surprise Percent
+17.39%

Description

Biocryst Pharmaceuticals (BCRX) has reported earnings of -0.19 per share for Q3 2023.

0 Comments

Share your thoughts